RFK Jr. Initiates Safety Review of Abortion Pill Amid Federal Scrutiny

RFK Jr. announced that the FDA will review the safety and efficacy of abortion pills, particularly mifepristone, amid political pressure from anti-abortion advocates. This review could lead to restrictions on the most common abortion method in the U.S., potentially impacting access, especially in states with bans. The move has been criticized by reproductive health organizations and advocates for undermining established safety data and access to medication abortion.